Method for vaccination against hepatitis B of persons with immunodeficiency

摘要

The invention relates to medicine and can be used in the prevention of viral hepatitis B to increase the effectiveness of vaccination.The method for vaccination consists in that simultaneously with hepatitis B vaccine is also administered an adaptogenic vegetal preparation with the active substance steroid glycoside 3-O-{¢α-L-rhamnopyranosyl(1→3)]-¢&bgr;-D-glucopyranosyl(1→2)]-&bgr;-D-glucopyranosyl}-¢(25R)-furost-5-en,3&bgr;,22α,26-triol]-26-O-&bgr;-D-glucopyranoside (Mestim), in tablets of 50 mg, one tablet in the morning 30 minutes before a meal, within 30 days, beginning with the first day of administration of the vaccine.The result consists in intensifying the process of immunogenesis expressed in an increased titer of protective antibodies, which leads to a reduction in the risk of HBV infection to a minimum for persons with immunodeficiency and a reduction in the number of persons, non-respondent to the vaccine.